Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arati Sharma

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|November 14, 2023
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid LeukemiaJohnson Ung, Su-Fern Tan, Todd E Fox, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Oncofetal RNA-binding proteins of IGF2BP family suppress IRF-3 and NF-kB dependent transcription downstream of cytosolic RNA sensorsGarrett Knox, Ruba Agili-Shaban, Alexis Morrissey, et al.
Cancers|December 23, 2023
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid LeukemiaJohnson Ung, Su-Fern Tan, Todd E Fox, et al.
Cancer Translational Medicine|September 12, 2017
SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia ModelsJeremy A Hengst, Taryn E Dick, Arati Sharma, et al.
Leukemia|June 24, 2025
Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemiaYali Ding, Bing He, Daniel Bogush, et al.
Frontiers in Oncology|April 17, 2020
The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid LeukemiaCharyguly Annageldiyev, Su-Fern Tan, Shreya Thakur, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 15, 2022
Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemiaAndrei V Khokhlatchev, Arati Sharma, Tye G Deering, et al.
Cell Reports|July 17, 2023
Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cellsFenghua Qian, Shaneice K Nettleford, Jiayan Zhou, et al.
Blood Reviews|April 29, 2022
Harnessing the power of sphingolipids: Prospects for acute myeloid leukemiaJohnson Ung, Su-Fern Tan, Todd E Fox, et al.
Nature Communications|March 30, 2021
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemiaGanqian Zhu, Huacheng Luo, Yang Feng, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|November 14, 2023
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid LeukemiaJohnson Ung, Su-Fern Tan, Todd E Fox, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Oncofetal RNA-binding proteins of IGF2BP family suppress IRF-3 and NF-kB dependent transcription downstream of cytosolic RNA sensorsGarrett Knox, Ruba Agili-Shaban, Alexis Morrissey, et al.
Cancers|December 23, 2023
Acid Ceramidase Inhibitor LCL-805 Antagonizes Akt Signaling and Promotes Iron-Dependent Cell Death in Acute Myeloid LeukemiaJohnson Ung, Su-Fern Tan, Todd E Fox, et al.
Cancer Translational Medicine|September 12, 2017
SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia ModelsJeremy A Hengst, Taryn E Dick, Arati Sharma, et al.
Leukemia|June 24, 2025
Critical roles of IKAROS and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemiaYali Ding, Bing He, Daniel Bogush, et al.
Frontiers in Oncology|April 17, 2020
The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid LeukemiaCharyguly Annageldiyev, Su-Fern Tan, Shreya Thakur, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 15, 2022
Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemiaAndrei V Khokhlatchev, Arati Sharma, Tye G Deering, et al.
Cell Reports|July 17, 2023
Activation of GPR44 decreases severity of myeloid leukemia via specific targeting of leukemia initiating stem cellsFenghua Qian, Shaneice K Nettleford, Jiayan Zhou, et al.
Blood Reviews|April 29, 2022
Harnessing the power of sphingolipids: Prospects for acute myeloid leukemiaJohnson Ung, Su-Fern Tan, Todd E Fox, et al.
Nature Communications|March 30, 2021
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemiaGanqian Zhu, Huacheng Luo, Yang Feng, et al.
Pageof 9